The effectiveness of these resale registrations opens the door for selling stockholders to unload shares at any time, likely creating persistent downward pressure. Traders should expect continued weakness and monitor for actual selling volume. The extreme dilution relative to market cap makes any near-term recovery unlikely without a fundamental catalyst.
Price Chart
Executive Summary
iSpecimen Inc.'s S-3 registration statement (File No. 333-296512) became effective on June 17, 2026, enabling selling stockholders to resell up to 488,290 shares from the May 2026 private placement. Combined with a prior S-3 covering up to 101,000,000 shares from Series C convertible preferred stock, the effectiveness creates massive potential dilution overhang relative to the company's $4M market cap.
Key Facts
- EFFECT notice confirms S-3 registration (File No. 333-296512) effective June 17, 2026.
- Registration covers resale of up to 488,290 shares (85,202 shares + 403,088 warrant shares) from May 2026 private placement.
- Prior S-3 (January 2026) covers resale of up to 101,000,000 shares issuable upon conversion of Series C Convertible Preferred Stock.
- Company receives no proceeds from resale; nominal proceeds (~$40) from cash exercise of pre-funded warrants.
- Market capitalization is approximately $4M, making potential dilution extreme.
Financial Impact
Potential dilution of up to 101,488,290 shares (101M from Jan S-3 + 488k from June S-3) against a $4M market cap, representing a massive increase in share count.
Risk Factors
- Immediate overhang from potential resale of up to 101.5M shares.
- Low liquidity and tiny market cap amplify price impact of any selling.
- Further dilutive offerings possible given the company's capital needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002047 |
| Document: 9999999995-26-002047-index.html | 9999999995-26-002047 |
| Document: 9999999995-26-002047.txt | 9999999995-26-002047 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $1.47 | awaiting T+60 | — | $0.8400 (+42.86%) |
Sep 4, 2026 7w ago | 8-K | $1.59 | awaiting T+60 | — | $0.8400 (−47.17%) |
Aug 14, 2026 10w ago | 8-K | $2.15 | awaiting T+60 | — | $0.8400 (+60.93%) |
Aug 7, 2026 11w ago | 8-K | $2.24 | awaiting T+60 | — | $0.8400 (+62.50%) |
Aug 7, 2026 11w ago | 424B4 | $2.22 | awaiting T+60 | — | $0.8400 (+62.16%) |
Jul 31, 2026 12w ago | EFFECT | $1.89 $0.8398 | ▲ +55.57% | ▲ +58.02% | $0.8400 (+55.56%) |
Jul 16, 2026 14w ago | S-1/A | $2.10 $1.08 | ▲ +48.57% | ▲ +53.25% | $0.8400 (+60.00%) |
Jul 14, 2026 14w ago | 8-K | $2.23 $1.09 | ▼ −51.12% | ▼ −53.65% | $0.8400 (−62.33%) |
Jun 18, 2026 18w ago | EFFECT | $2.59 $1.47 | ▲ +43.24% | ▲ +45.14% | $0.8400 (+67.57%) |
Jun 1, 2026 21w ago | 8-K | $3.07 $1.64 | ▲ +46.58% | ▲ +47.70% | $0.8400 (+72.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers